SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009681
Filing Date
2020-08-06
Accepted
2020-08-06 16:28:59
Documents
73
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20200630x10q.htm   iXBRL 10-Q 2089689
2 EX-10.1 ptgx-20200630xex10d1.htm EX-10.1 38034
3 EX-31.1 ptgx-20200630xex31d1.htm EX-31.1 10102
4 EX-31.2 ptgx-20200630xex31d2.htm EX-31.2 9928
5 EX-32.1 ptgx-20200630xex32d1.htm EX-32.1 9471
6 GRAPHIC ptgx-20200630x10q007.jpg GRAPHIC 53060
  Complete submission text file 0001558370-20-009681.txt   8061756

Data Files

Seq Description Document Type Size
7 EX-101.SCH ptgx-20200630.xsd EX-101.SCH 55951
8 EX-101.CAL ptgx-20200630_cal.xml EX-101.CAL 52760
9 EX-101.DEF ptgx-20200630_def.xml EX-101.DEF 187386
10 EX-101.LAB ptgx-20200630_lab.xml EX-101.LAB 453724
11 EX-101.PRE ptgx-20200630_pre.xml EX-101.PRE 371302
12 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20200630x10q_htm.xml XML 1387368
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 201082149
SIC: 2834 Pharmaceutical Preparations